Update 2022

I have been busy recently and couldn’t keep up with news recently, so they come in bulk!

Measurement Invariance workshop

We’re organising a workshop an measurement invariance testing in a CFA framework for categorical indicators with Terrence Jorgensen, who really is a capacity! It will take place online on Feb, 10th, 2pm CET - drop me an email if you’d like to join.

We moved!

New offices, really neat. Currently torturing our brains on how to most effectively use the additional space.

Looking forward to host Conrad Harrison in 2022

Our colleague Conrad Harrison got some founding from the OX/BER Research Partnership for a short stay at our group in Berlin. We will jointly work on some analysis about plausible value imputation in clinical trials! Really looking forward to it.

And a few new publications:

• Letter to the editor on a paper reporting depression prevalence in Europe: PHQ-8 scores and estimation of depression prevalence

• Paul Klapproth’s work on comparing the PROPr and the EQ-5D in the European general population: Comparison of the PROMIS Preference Score (PROPr) and EQ-5D-5L Index Value in General Population Samples in the United Kingdom, France, and Germany

• From the DEPRESSD team a validation of a shortened PHQ Depression scale: External validation of a shortened screening tool using individual participant data meta-analysis: A case study of the Patient Health Questionnaire-Dep-4
• Study protocol for the PRO-B trial: PRO B: evaluating the effect of an alarm-based patient-reported outcome monitoring compared with usual care in metastatic breast cancer patients—study protocol for a randomised controlled trial
• Here we used a common depression metric to be able to analyze data from 2 studies in one go: Immune signature of multiple sclerosis-associated depression